Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Insulin-like factor 3 as a marker of testicular function in obese men.

Foresta C, Di Mambro A, Pagano C, Garolla A, Vettor R, Ferlin A.

Clin Endocrinol (Oxf). 2009 Nov;71(5):722-6. doi: 10.1111/j.1365-2265.2009.03549.x. Epub 2009 Feb 18.

PMID:
19226271
2.

Phthalates might interfere with testicular function by reducing testosterone and insulin-like factor 3 levels.

Chang WH, Li SS, Wu MH, Pan HA, Lee CC.

Hum Reprod. 2015 Nov;30(11):2658-70. doi: 10.1093/humrep/dev225. Epub 2015 Sep 18.

PMID:
26385792
3.

Decreased androgen levels in massively obese men may be associated with impaired function of the gonadostat.

Lima N, Cavaliere H, Knobel M, Halpern A, Medeiros-Neto G.

Int J Obes Relat Metab Disord. 2000 Nov;24(11):1433-7.

PMID:
11126339
4.

Body mass index in relation to semen quality and reproductive hormones in New Zealand men: a cross-sectional study in fertility clinics.

Macdonald AA, Stewart AW, Farquhar CM.

Hum Reprod. 2013 Dec;28(12):3178-87. doi: 10.1093/humrep/det379. Epub 2013 Oct 15.

PMID:
24129611
5.

Peripheral INSL3 concentrations decline with age in a large population of Australian men.

Anand-Ivell R, Wohlgemuth J, Haren MT, Hope PJ, Hatzinikolas G, Wittert G, Ivell R.

Int J Androl. 2006 Dec;29(6):618-26. Epub 2006 Oct 3.

PMID:
17014531
6.

Changes in serum insulin-like factor 3 during normal male puberty.

Ferlin A, Garolla A, Rigon F, Rasi Caldogno L, Lenzi A, Foresta C.

J Clin Endocrinol Metab. 2006 Sep;91(9):3426-31. Epub 2006 Jun 27.

PMID:
16804040
7.

Relationship between BMI, total testosterone, sex hormone-binding-globulin, leptin, insulin and insulin resistance in obese men.

Osuna JA, Gómez-Pérez R, Arata-Bellabarba G, Villaroel V.

Arch Androl. 2006 Sep-Oct;52(5):355-61.

PMID:
16873135
8.

Low INSL3 in Klinefelter syndrome is related to osteocalcin, testosterone treatment and body composition, as well as measures of the hypothalamic-pituitary-gonadal axis.

Overvad S, Bay K, Bojesen A, Gravholt CH.

Andrology. 2014 May;2(3):421-7. doi: 10.1111/j.2047-2927.2014.00204.x. Epub 2014 Mar 21.

9.
10.

A strong association between biologically active testosterone and leptin in non-obese men and women is lost with increasing (central) adiposity.

Söderberg S, Olsson T, Eliasson M, Johnson O, Brismar K, Carlström K, Ahrén B.

Int J Obes Relat Metab Disord. 2001 Jan;25(1):98-105.

PMID:
11244464
11.

Insulin-like factor 3 serum levels in 135 normal men and 85 men with testicular disorders: relationship to the luteinizing hormone-testosterone axis.

Bay K, Hartung S, Ivell R, Schumacher M, Jürgensen D, Jorgensen N, Holm M, Skakkebaek NE, Andersson AM.

J Clin Endocrinol Metab. 2005 Jun;90(6):3410-8. Epub 2005 Mar 8.

PMID:
15755855
12.

Human testicular insulin-like factor 3: in relation to development, reproductive hormones and andrological disorders.

Bay K, Andersson AM.

Int J Androl. 2011 Apr;34(2):97-109. doi: 10.1111/j.1365-2605.2010.01074.x. Review.

PMID:
20550598
13.

Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex-hormone binding globulin levels in men: cross-sectional data from a healthy male cohort.

Leifke E, Gorenoi V, Wichers C, Von Zur Mühlen A, Von Büren E, Brabant G.

Clin Endocrinol (Oxf). 2000 Dec;53(6):689-95.

PMID:
11155090
14.

Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men.

Vermeulen A, Kaufman JM, Deslypere JP, Thomas G.

J Clin Endocrinol Metab. 1993 May;76(5):1140-6.

PMID:
8496304
15.

Insulin-like peptide 3 (INSL3) in men with congenital hypogonadotropic hypogonadism/Kallmann syndrome and effects of different modalities of hormonal treatment: a single-center study of 281 patients.

Trabado S, Maione L, Bry-Gauillard H, Affres H, Salenave S, Sarfati J, Bouvattier C, Delemer B, Chanson P, Le Bouc Y, Brailly-Tabard S, Young J.

J Clin Endocrinol Metab. 2014 Feb;99(2):E268-75. doi: 10.1210/jc.2013-2288. Epub 2013 Nov 15.

PMID:
24243640
16.

Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.

De Pergola G, De Mitrio V, Sciaraffia M, Pannacciulli N, Minenna A, Giorgino F, Petronelli M, Laudadio E, Giorgino R.

Metabolism. 1997 Nov;46(11):1287-93.

PMID:
9361687
17.

Testosterone and obesity in men under the age of 40 years.

Goncharov NP, Katsya GV, Chagina NA, Gooren LJ.

Andrologia. 2009 Apr;41(2):76-83. doi: 10.1111/j.1439-0272.2008.00863.x.

PMID:
19260842
18.

Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.

Pasquali R, Vicennati V, Bertazzo D, Casimirri F, Pascal G, Tortelli O, Labate AM.

Metabolism. 1997 Jan;46(1):5-9.

PMID:
9005961
19.

Peripheral insulin-like factor 3 concentrations are reduced in men with type 2 diabetes mellitus: effect of glycemic control and visceral adiposity on Leydig cell function.

Ermetici F, Donadio F, Iorio L, Malavazos AE, Dolci A, Peverelli E, Barbieri AM, Morricone L, Chiodini I, Arosio M, Lania A, Beck-Peccoz P, Ambrosi B, Corbetta S.

Eur J Endocrinol. 2009 Dec;161(6):853-9. doi: 10.1530/EJE-09-0203. Epub 2009 Sep 15.

20.

Supplemental Content

Support Center